Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.
about
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Hedgehog Signaling in the Maintenance of Cancer Stem CellsCholangiocarcinomaStem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancerSensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell CulturesRole of liver stem cells in hepatocarcinogenesis.Pathogenesis, diagnosis, and management of cholangiocarcinomaAnti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer.Capsaicin treatment attenuates cholangiocarcinoma carcinogenesisFBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cellsThe Prognostic Role of SOCS3 and A20 in Human CholangiocarcinomaAdrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition.Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Amarogentin regulates self renewal pathways to restrict liver carcinogenesis in experimental mouse model.Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer.Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer.Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma.Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma.Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.Emerging molecular therapeutic targets for cholangiocarcinoma.Emerging concepts in biliary repair and fibrosis.Hedgehog signalling in liver pathophysiology.Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview.Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma.Hedgehog pathway as a potential treatment target in human cholangiocarcinoma.Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma.Role of canonical Hedgehog signaling pathway in liver
P2860
Q26771988-FFB2FC16-CBD2-42EC-8685-3FCAB7472924Q26798191-C8919D8D-4949-4F73-8E0B-79B6E5CD8F9EQ27001694-A0B21C93-70BC-4016-A64F-490ED0624761Q28079205-6199FA60-D67D-4BFB-B57C-E559FD73120BQ28550991-69B99244-EA05-4E5B-AB2A-B1CBCEE10024Q34259112-06CA0FC6-1B8D-4CE1-BB8E-5B859F09F0D5Q34656747-A4F859C0-2820-41AA-906A-7287D0B4179BQ34898364-58EACAD0-8B27-4FA2-8727-C036A169750BQ35051953-35954B18-5CF0-48B9-8248-6D30DF039624Q35153098-F1C4290B-5EC5-46CE-95C3-15E4B84F1610Q35742526-9B3CCD73-CC46-473E-BFAD-18C531712487Q35814659-3DA576E0-DCC8-44BE-8A82-99D0B3256363Q35869828-32538945-4F3D-4D73-A99B-6A8F738F4A88Q36199767-A80411CD-E8B7-4F64-A56F-ED4331FE45ACQ37262757-B511D211-05E1-4BED-9907-A4914B98507EQ38152382-55A28FCE-0089-4486-B616-5613AB5EC63DQ38720813-DB7362D8-41D3-43D4-B525-9A8C2D7E2E02Q38812588-C093D171-1B56-4530-846A-E7064FB60F93Q38855460-7B25F71E-2539-4F12-884F-D68674A8D6E9Q38903263-1282786E-87CD-4133-A4A7-DE238681AE70Q38943859-C98E852C-64B2-4B38-91D0-7FE02073742EQ38971418-472DA5E3-9A4D-4D28-998A-679DB721E235Q39010123-AAB58187-C1B7-48DA-8EDE-1D7A91592C5DQ39062578-1A3CB2B9-3DA3-4AE9-B131-4587F2697079Q39179218-0F07209A-2F8E-431B-81AF-18853F94EDAAQ39227356-E019DED0-E7AC-4701-BEF9-3268265F2654Q39319145-3058FFB8-B671-4CED-9E41-B3B35B7BE17FQ47589566-45DA7911-2630-4DAA-A47E-BE291F09251BQ47603972-58C7E183-2CA4-4517-9F25-BF71B481A04DQ52729640-69017BD1-5D49-40B4-8613-C66F6E9B9025Q52877592-291B989D-08AE-44A7-AE93-B7B2616B9CAFQ55032209-F051529D-980A-496F-97B1-EA5738E302CBQ58758006-2E8E8651-95CB-4BFB-81E5-E138DCEDBCA4
P2860
Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of hedgehog signali ...... f cholangiocellular carcinoma.
@en
Inhibition of hedgehog signali ...... f cholangiocellular carcinoma.
@nl
type
label
Inhibition of hedgehog signali ...... f cholangiocellular carcinoma.
@en
Inhibition of hedgehog signali ...... f cholangiocellular carcinoma.
@nl
prefLabel
Inhibition of hedgehog signali ...... f cholangiocellular carcinoma.
@en
Inhibition of hedgehog signali ...... f cholangiocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of hedgehog signali ...... of cholangiocellular carcinoma
@en
P2093
Anna Kalnytska
Ludwig Wilkens
Michael P Manns
Mona El Khatib
Nisar P Malek
Ruben R Plentz
Vindhya Palagani
P2860
P304
P356
10.1002/HEP.26147
P407
P50
P577
2013-01-25T00:00:00Z